We aimed to investigate the effects of CMs, obtained from both ADAM12/CYP1B1 expressing (control), and knocked down (silenced) adipocytes from RCC patients with different stages of BMI on the migration of RCC cells. Here, ADAM12 is linked to renal cell carcinoma.